INL1

· Innolife Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INL1, covering 2022-03-31 to 2022-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction [Phase 2]